(Q45795502)

16 December 2017

title

Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus (English)

1 reference

16 December 2017

7

Purcell RH

1 reference

16 December 2017

John L. Gerin

8

object named as

Gerin JL

1 reference

16 December 2017

author name string

Ponzetto A

1

1 reference

16 December 2017

Seeff LB

2

1 reference

16 December 2017

Buskell-Bales Z

3

1 reference

16 December 2017

Ishak KG

4

1 reference

16 December 2017

Hoofnagle JH

5

1 reference

16 December 2017

Zimmerman HJ

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 1984

1 reference

16 December 2017

published in

Hepatology

1 reference

16 December 2017

volume

4

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

page(s)

1111-1115

1 reference

16 December 2017

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Levamisole and chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

δ antigen in hepatitis B: Immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Infection with delta agent in Sweden: introduction of a new hepatitis agent

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

U. K. prevalence of delta infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Delta agent in Britain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040603

7 January 2021

Identifiers

DOI

10.1002/HEP.1840040603

1 reference

16 December 2017

1 reference

16 December 2017